CDEK
← All organizations

Fosun

For profit

Also known as: Ahon Pharmaceutical Co., Ltd. | Fosun Adgenvax Biopharmaceutical Co.,Ltd. | Fosun Pharma | FOSUN PHARMA | FOSUN WANBANG (JIANGSU) PHARMACEUTICAL GROUP CO., | GLAND PHARMA LIMITED | Jiangsu Wanbang Pharmaceutical Marketing Co.,Ltd. | Orinove, Inc. | Shanghai Fosun Pharmaceutical Development Co, Ltd. | Shanghai Fosun Pharmaceutical Industrial Development Co, Ltd. | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | Yaopharma | Yaopharma Co., Ltd. | YAOPHARMA CO LTD

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Sep 28, 2015

First marketed drug

Mar 12, 1959

Last known activity

Mar 11, 2026

Timeline

1930s

  1. Jun 1, 1939

    Fosun— Founded

1980s

  1. Jun 29, 1984

    methyldopa— NDA Secondary Org

2010s

  1. Oct 4, 2017

    Gland Pharma Ltd— Acquired

  2. Aug 2, 2019

    olopatadine— Marketing Organization

2020s

  1. Oct 27, 2021

    Chengdu Antejin Biotech— Acquired

Drugs by trial phase (33 distinct, 38 trials)

Other trials (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (148)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (39)

Details

Founded
Chongqing, CN Jun 1, 1939
Last known activity
Mar 11, 2026

Notes

--- Pre-folding founded info: 1992-01-01 Shanghai None China https://en.wikipedia.org/wiki/Fosun ---